Free Trial
NASDAQ:AKYA

Akoya Biosciences (AKYA) Stock Price, News & Analysis

Akoya Biosciences logo
$1.29 0.00 (0.00%)
As of 07/8/2025

About Akoya Biosciences Stock (NASDAQ:AKYA)

Key Stats

Today's Range
$1.29
$1.29
50-Day Range
$0.95
$1.37
52-Week Range
$0.93
$3.42
Volume
N/A
Average Volume
409,353 shs
Market Capitalization
$64.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.51
Consensus Rating
Hold

Company Overview

Akoya Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
40th Percentile Overall Score

AKYA MarketRank™: 

Akoya Biosciences scored higher than 40% of companies evaluated by MarketBeat, and ranked 702nd out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Akoya Biosciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 7 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Akoya Biosciences has only been the subject of 1 research reports in the past 90 days.

  • Read more about Akoya Biosciences' stock forecast and price target.
  • Earnings Growth

    Earnings for Akoya Biosciences are expected to grow in the coming year, from ($0.96) to ($0.64) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Akoya Biosciences is -1.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Akoya Biosciences is -1.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Akoya Biosciences has a P/B Ratio of 8.60. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Akoya Biosciences' valuation and earnings.
  • Percentage of Shares Shorted

    12.67% of the float of Akoya Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Akoya Biosciences has a short interest ratio ("days to cover") of 5.7.
  • Change versus previous month

    Short interest in Akoya Biosciences has recently decreased by 7.04%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Akoya Biosciences does not currently pay a dividend.

  • Dividend Growth

    Akoya Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.67% of the float of Akoya Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Akoya Biosciences has a short interest ratio ("days to cover") of 5.7.
  • Change versus previous month

    Short interest in Akoya Biosciences has recently decreased by 7.04%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Akoya Biosciences has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Akoya Biosciences this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Akoya Biosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.30% of the stock of Akoya Biosciences is held by insiders.

  • Percentage Held by Institutions

    79.42% of the stock of Akoya Biosciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Akoya Biosciences' insider trading history.
Receive AKYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akoya Biosciences and its competitors with MarketBeat's FREE daily newsletter.

AKYA Stock News Headlines

AKYA Akoya Biosciences, Inc. - Seeking Alpha
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
See More Headlines

AKYA Stock Analysis - Frequently Asked Questions

Akoya Biosciences' stock was trading at $2.29 at the beginning of the year. Since then, AKYA shares have decreased by 43.7% and is now trading at $1.29.

Akoya Biosciences, Inc. (NASDAQ:AKYA) announced its quarterly earnings data on Monday, May, 12th. The company reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.29) by $0.03. The business had revenue of $16.64 million for the quarter, compared to analyst estimates of $20.19 million. Akoya Biosciences had a negative trailing twelve-month return on equity of 487.85% and a negative net margin of 59.44%.

Akoya Biosciences (AKYA) raised $125 million in an initial public offering on Friday, April 16th 2021. The company issued 6,600,000 shares at $18.00-$20.00 per share. J.P. Morgan, Morgan Stanley, Piper Sandler and Canaccord Genuity acted as the underwriters for the IPO.

Shares of AKYA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Akoya Biosciences investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Broadcom (AVGO), Invesco QQQ (QQQ) and Palo Alto Networks (PANW).

Company Calendar

Last Earnings
5/12/2025
Today
7/14/2025
Next Earnings (Estimated)
8/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:AKYA
CIK
1711933
Fax
N/A
Employees
90
Year Founded
N/A

Price Target and Rating

High Price Target
$5.00
Low Price Target
$1.08
Potential Upside/Downside
+94.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.97)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$55.37 million
Net Margins
-59.44%
Pretax Margin
-59.28%
Return on Equity
-487.85%
Return on Assets
-35.86%

Debt

Debt-to-Equity Ratio
10.12
Current Ratio
0.61
Quick Ratio
0.40

Sales & Book Value

Annual Sales
$79.96 million
Price / Sales
0.81
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.15 per share
Price / Book
8.60

Miscellaneous

Outstanding Shares
49,954,000
Free Float
46,307,000
Market Cap
$64.44 million
Optionable
Optionable
Beta
1.36
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:AKYA) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners